Nervgen Pharma NGEN
NASDAQ NGEN
$1.52 -0.01 (-0.97%)
As of: Oct 21, 2026 · 10:31 AM EDT

Nervgen Pharma (NGEN) Total Non-Current Liabilities (2024 - 2026)

Updated

Nervgen Pharma (NGEN) recorded Total Non-Current Liabilities of -$12.49 million in the quarter ended Jun 30, 2026.

Analysis

Nervgen Pharma (NGEN) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Nervgen Pharma reported Total Non-Current Liabilities of -$2.49 million.

  • Across earlier years, Total Non-Current Liabilities came in at $6,113 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.80 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 614.95 Bn 533.47 Bn 17.26 Bn 105.50 Bn
3 AbbVie 505.05 Bn 478.16 Bn 12.70 Bn 106.45 Bn
4 Merck 368.08 Bn 322.46 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.32 Bn 262.31 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.58 Bn 235.26 Bn 12.86 Bn 33.91 Bn
7 Amgen 236.05 Bn 191.45 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 190.61 Bn 164.80 Bn 6.22 Bn 35.10 Bn
9 Pfizer 169.86 Bn 116.50 Bn 10.94 Bn 97.04 Bn
10 Nervgen Pharma 110.30 Mn 9.19 Mn - 3.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.02 Mn
Mar 31, 2026 4.22 Mn
Dec 31, 2025 3.41 Mn
Dec 31, 2024 5,832.14
API Access

Nervgen Pharma Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=NGEN&period=max&api_key=YOUR_API_KEY